血清胆汁酸概况与冠状动脉疾病患者的死亡率之间的关联:一项队列研究
Yupeng Zeng1, Qing Li1, Xinyuan Jin1
1Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong Province, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, Guangdong Province, China.
The American journal of clinical nutrition
|September 21, 2025
概括
含量较高的特定胆酸,包括胆酸 (CA) 和胆酸 (CDCA),与冠状动脉疾病 (CAD) 患者的死亡风险降低有关. 这些发现突出了胆酸的含量.
科学领域:
- 代谢学和心血管研究.
- 胆固醇代谢和疾病的发生
- 动脉样硬化中的生物标志物
背景情况:
- 胆汁酸,胆固醇代谢物,调节葡萄糖,脂质和免疫功能.
- 有限的研究存在于循环胆酸和冠状动脉疾病 (CAD) 之间的关联.
研究的目的:
- 为了研究血清胆汁酸概况和诊断为CAD的患者的死亡率之间的关系.
主要方法:
- 在1730名CAD患者中测量了15种胆汁酸的血清度.
- 采用了超高性能液体染色学-并联质谱法.
- 考克斯的比例危险回归模型评估了与死亡风险的关联.
主要成果:
- 随访时间为9.2年,共发现405例全因死亡和261例心血管死亡.
- 高血清度的胆酸 (CA),氧胆酸 (CDCA),脱氧胆酸 (DCA) 和氧胆酸 (HDCA) 与心血管和全因死亡率的降低相关.
- 胆汁酸和临床因素 (BMI,CAD类型,糖尿病,年龄) 之间的相互作用是显著的.
结论:
- 特定非结合胆酸 (CA,CDCA,DCA,HDCA) 的血清水平升高与CAD患者的死亡率降低有关.
- 这些胆汁酸可以作为潜在的预后生物标志物,用于心血管疾病的结果.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
557
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
557
Coronary Artery Disease IV: Preventive Measures
590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
Coronary Artery Disease III: Clinical Manifestations
330
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
330
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322

